vs
Side-by-side financial comparison of PERRIGO Co plc (PRGO) and RXO, Inc. (RXO). Click either name above to swap in a different company.
RXO, Inc. is the larger business by last-quarter revenue ($1.5B vs $1.1B, roughly 1.3× PERRIGO Co plc). RXO, Inc. runs the higher net margin — -3.1% vs -127.8%, a 124.7% gap on every dollar of revenue. On growth, PERRIGO Co plc posted the faster year-over-year revenue change (-2.5% vs -11.9%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $-9.0M). Over the past eight quarters, RXO, Inc.'s revenue compounded faster (26.8% CAGR vs 1.3%).
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
RXO, Inc. is a leading transportation and logistics solutions provider headquartered in the United States. Its core service portfolio includes freight brokerage, last-mile delivery for heavy and bulky goods, managed transportation services, and end-to-end supply chain optimization support, primarily catering to clients across the North American manufacturing, retail, and e-commerce segments.
PRGO vs RXO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.5B |
| Net Profit | $-1.4B | $-46.0M |
| Gross Margin | 32.6% | — |
| Operating Margin | -116.0% | -2.9% |
| Net Margin | -127.8% | -3.1% |
| Revenue YoY | -2.5% | -11.9% |
| Net Profit YoY | -3093.9% | -84.0% |
| EPS (diluted) | $-10.23 | $-0.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $1.0B | $1.4B | ||
| Q2 25 | $1.1B | $1.4B | ||
| Q1 25 | $1.0B | $1.4B | ||
| Q4 24 | $1.1B | $1.7B | ||
| Q3 24 | $1.1B | $1.0B | ||
| Q2 24 | $1.1B | $930.0M | ||
| Q1 24 | $1.1B | $913.0M |
| Q4 25 | $-1.4B | $-46.0M | ||
| Q3 25 | $7.5M | $-14.0M | ||
| Q2 25 | $-8.4M | $-9.0M | ||
| Q1 25 | $-6.4M | $-31.0M | ||
| Q4 24 | $-44.4M | $-25.0M | ||
| Q3 24 | $-21.0M | $-243.0M | ||
| Q2 24 | $-108.4M | $-7.0M | ||
| Q1 24 | $2.0M | $-15.0M |
| Q4 25 | 32.6% | — | ||
| Q3 25 | 36.1% | — | ||
| Q2 25 | 34.4% | — | ||
| Q1 25 | 37.6% | — | ||
| Q4 24 | 33.9% | — | ||
| Q3 24 | 37.2% | — | ||
| Q2 24 | 37.0% | — | ||
| Q1 24 | 33.1% | — |
| Q4 25 | -116.0% | -2.9% | ||
| Q3 25 | 7.0% | -0.5% | ||
| Q2 25 | 4.3% | — | ||
| Q1 25 | 4.5% | -2.1% | ||
| Q4 24 | 10.0% | -1.4% | ||
| Q3 24 | 7.4% | -1.9% | ||
| Q2 24 | -2.5% | — | ||
| Q1 24 | -5.1% | -1.3% |
| Q4 25 | -127.8% | -3.1% | ||
| Q3 25 | 0.7% | -1.0% | ||
| Q2 25 | -0.8% | -0.6% | ||
| Q1 25 | -0.6% | -2.2% | ||
| Q4 24 | -3.9% | -1.5% | ||
| Q3 24 | -1.9% | -23.4% | ||
| Q2 24 | -10.2% | -0.8% | ||
| Q1 24 | 0.2% | -1.6% |
| Q4 25 | $-10.23 | $-0.28 | ||
| Q3 25 | $0.05 | $-0.08 | ||
| Q2 25 | $-0.06 | $-0.05 | ||
| Q1 25 | $-0.05 | $-0.18 | ||
| Q4 24 | $-0.32 | $-0.17 | ||
| Q3 24 | $-0.15 | $-1.81 | ||
| Q2 24 | $-0.79 | $-0.06 | ||
| Q1 24 | $0.01 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $17.0M |
| Total DebtLower is stronger | — | $387.0M |
| Stockholders' EquityBook value | $2.9B | $1.5B |
| Total Assets | $8.5B | $3.3B |
| Debt / EquityLower = less leverage | — | 0.25× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $17.0M | ||
| Q3 25 | $432.1M | $25.0M | ||
| Q2 25 | $454.2M | $18.0M | ||
| Q1 25 | $409.9M | $16.0M | ||
| Q4 24 | $558.8M | $35.0M | ||
| Q3 24 | $1.5B | $55.0M | ||
| Q2 24 | $542.8M | $7.0M | ||
| Q1 24 | $658.5M | $7.0M |
| Q4 25 | — | $387.0M | ||
| Q3 25 | — | $387.0M | ||
| Q2 25 | — | $387.0M | ||
| Q1 25 | — | $387.0M | ||
| Q4 24 | — | $351.0M | ||
| Q3 24 | — | $352.0M | ||
| Q2 24 | — | $370.0M | ||
| Q1 24 | — | $351.0M |
| Q4 25 | $2.9B | $1.5B | ||
| Q3 25 | $4.4B | $1.6B | ||
| Q2 25 | $4.5B | $1.6B | ||
| Q1 25 | $4.4B | $1.6B | ||
| Q4 24 | $4.3B | $1.6B | ||
| Q3 24 | $4.6B | $1.7B | ||
| Q2 24 | $4.5B | $579.0M | ||
| Q1 24 | $4.7B | $582.0M |
| Q4 25 | $8.5B | $3.3B | ||
| Q3 25 | $10.1B | $3.2B | ||
| Q2 25 | $10.1B | $3.2B | ||
| Q1 25 | $9.8B | $3.3B | ||
| Q4 24 | $9.6B | $3.4B | ||
| Q3 24 | $11.2B | $3.4B | ||
| Q2 24 | $10.4B | $1.8B | ||
| Q1 24 | $10.6B | $1.8B |
| Q4 25 | — | 0.25× | ||
| Q3 25 | — | 0.24× | ||
| Q2 25 | — | 0.24× | ||
| Q1 25 | — | 0.24× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.64× | ||
| Q1 24 | — | 0.60× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.4M | $7.0M |
| Free Cash FlowOCF − Capex | $148.6M | $-9.0M |
| FCF MarginFCF / Revenue | 13.4% | -0.6% |
| Capex IntensityCapex / Revenue | 2.4% | 1.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $145.1M | $-8.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $175.4M | $7.0M | ||
| Q3 25 | $51.7M | $23.0M | ||
| Q2 25 | $75.9M | $23.0M | ||
| Q1 25 | $-64.5M | $-2.0M | ||
| Q4 24 | $312.6M | $-7.0M | ||
| Q3 24 | $42.2M | $-7.0M | ||
| Q2 24 | $9.5M | $-5.0M | ||
| Q1 24 | $-1.4M | $7.0M |
| Q4 25 | $148.6M | $-9.0M | ||
| Q3 25 | $29.8M | $9.0M | ||
| Q2 25 | $56.7M | $9.0M | ||
| Q1 25 | $-90.0M | $-17.0M | ||
| Q4 24 | $274.9M | $-19.0M | ||
| Q3 24 | $15.1M | $-18.0M | ||
| Q2 24 | $-18.9M | $-16.0M | ||
| Q1 24 | $-26.5M | $-4.0M |
| Q4 25 | 13.4% | -0.6% | ||
| Q3 25 | 2.9% | 0.6% | ||
| Q2 25 | 5.4% | 0.6% | ||
| Q1 25 | -8.6% | -1.2% | ||
| Q4 24 | 24.2% | -1.1% | ||
| Q3 24 | 1.4% | -1.7% | ||
| Q2 24 | -1.8% | -1.7% | ||
| Q1 24 | -2.4% | -0.4% |
| Q4 25 | 2.4% | 1.1% | ||
| Q3 25 | 2.1% | 1.0% | ||
| Q2 25 | 1.8% | 1.0% | ||
| Q1 25 | 2.4% | 1.0% | ||
| Q4 24 | 3.3% | 0.7% | ||
| Q3 24 | 2.5% | 1.1% | ||
| Q2 24 | 2.7% | 1.2% | ||
| Q1 24 | 2.3% | 1.2% |
| Q4 25 | — | — | ||
| Q3 25 | 6.89× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.70× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
RXO
| Retail Sector | $546.0M | 37% |
| Last Mile | $298.0M | 20% |
| Food And Beverage Sector | $225.0M | 15% |
| Other Sector | $185.0M | 13% |
| Managed Transportation | $133.0M | 9% |
| Automotive Sector | $93.0M | 6% |
